Medicamen Biotech Limited researches, develops, manufactures, markets, sells, and distributes pharmaceutical formulations and APIs in India. The company offers a range of products, including tablets, such as non-beta lactam tablets; capsules comprising beta and non-beta lactam capsules; liquid and dry syrups; and ointments and creams. It also provides oral solid and liquid products. The company's products are used in various therapeutic areas, such as gastrointestinal, pain management, anti-infectives, pediatrics, dermatology, gynecology and rheumatology, diabetology, cardiology, oncology, and the central nervous system. Medicamen Biotech Limited was incorporated in 1993 and is based in New Delhi, India.
Stock data | 2023 | Change |
---|---|---|
Price | $5.61 | N/A |
Market Cap | $69.94M | N/A |
Shares Outstanding | 12.46M | 1.96% |
Employees | 388.00 | N/A |
Shareholder Equity | 1.93B | 32.05% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 0.47 | N/A |
P/S Ratio | 4.16 | N/A |
P/B Ratio | 0.04 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0009 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $16.81M | N/A |
Earnings | $1.76M | N/A |
EPS | 11.82 | N/A |
Earnings Yield | 2.11 | N/A |
Gross Margin | 0.4882 | N/A |
Operating Margin | 0.1243 | N/A |
Net income margin | 0.1046 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $33.25M | N/A |
Total Debt | $2.89M | N/A |
Cash on Hand | $2.48M | N/A |
Debt to Equity | 0.0053 | -18.65% |
Cash to Debt | 0.8592 | 479.50% |
Current Ratio | $1.98 | 16.88% |